XML 13 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Statements of Financial Condition - USD ($)
Jun. 30, 2020
Dec. 31, 2019
U.S. Equity Cumulative Dividends Fund-Series 2027    
Assets    
Investments, at Fair Value (Cost) $ 18,427,314 $ 23,583,730
Cash and Cash Equivalents 575,914 536,334
Cash pledged as collateral on Futures Contracts 313,774 518,511
Interest Receivable 27,962 48,910
Variation Margin Receivable 158,875 35,875
Total Assets 19,503,839 24,723,360
Liabilities    
Due to Advisor 13,636 18,094
Variation Margin Payable   20,500
Income Distribution Payable 312,625 307,500
Other Accrued Expenses 68,580 86,737
Total Liabilities 394,841 432,831
Shareholders' Equity    
Authorized Participants (Shares Outstanding) $ 19,108,998 $ 24,290,529
Net Asset Value Per Share $ 9.32 $ 11.85
Market Price Per Share $ 9.73 $ 11.88
U.S. Equity Ex-Dividend Fund-Series 2027    
Assets    
Investments, at Fair Value (Cost) $ 25,785,222 $ 25,837,538
Cash and Cash Equivalents 609,545 110,135
Cash pledged as collateral on Futures Contracts 611,692 1,024,173
Variation Margin Receivable 425,000 81,000
Total Assets 27,431,459 27,052,846
Liabilities    
Payable for Securities Purchased 499,721
Due to Advisor 12,745 13,037
Variation Margin Payable 31,000 7,000
Other Accrued Expenses 67,120 91,007
Total Liabilities 610,586 111,044
Shareholders' Equity    
Authorized Participants (Shares Outstanding) $ 26,820,873 $ 26,941,802
Net Asset Value Per Share $ 67.05 $ 67.35
Market Price Per Share $ 66.86 $ 67.11